glp-1 and gip receptor agonist GLP-1/GIP Agonists Diabetic Retinopathy: What ODs Should Know New Developments in Pharmacological Treatment
Description
The ACR Convergence 2025 data specifically showed additive benefit when GLP-1 agonists were combined with DMARDs
Gromada J, Franklin I, Wollheim CB
Youll walk away with a completely new toolkit for breaking through patient resistance, dissolving medication hesitancy, and creating clinical encounters that actually inspire change!
Combining physical activity with a balanced diet is recommended for maximum weight management effectiveness
Obesity Prevalence and Treatment Paradigm Shift: With over one billion people globally living with obesity and only a fraction receiving pharmacotherapy, the addressable market dwarfs diabetes alone [1]
